The mode of inactivation of TP53 is unique compared to other tumor suppressor genes, with more than 80% of somatic and germline TP53 alterations being missense mutations that lead to the synthesis of a stable mutant protein that accumulates in the nucleus of tumor cells (24). This evidence concerns the gene TP53 and neoplasm.